Please try another search
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Christophe D. Chassagnole | - | 2007 | Chief Scientific Officer & Executive Director |
Robert Jackson | 80 | - | Consultant & Member of Scientific Advisory Board |
Peter Joseph Sargent | 46 | 2023 | CEO, COO & Director |
James Simon Millen | 55 | 2016 | Non-Executive Chairman |
David Fell | - | - | Co-Founder & Member of Scientific Advisory Board |
Mark Middleton | - | 2015 | Consultant & Member of Scientific Advisory Board |
Timothy H. Corn | 73 | 2022 | Independent Non-Executive Director |
Shalabh Kumar | 57 | 2022 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review